T he role of neutrophils in cancer is controversial, owing to the seemingly contradictory ability of these cells to either promote tumor growth or exert antitumor effects 1-5 . The identification of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), which are pathologically activated polymorphonuclear cells (PMNs) that accumulate in cancer and are characterized by immunosuppressive and pro-tumorigenic activity, helped to partially resolve this controversy 3 . It is also suggested that some neutrophils that accumulate in cancer and chronic inflammation contribute to tumor development and progression without eliciting immunosuppressive activity 6,7 . These cells have been provisionally called 'MDSC-like' cells 8 . However, the characteristics of these cells and their distinction from control neutrophils in tumor-free hosts have yet to be defined.
Results
Enhanced motility of BM neutrophils in TB mice depends on the stage of the tumor. We evaluated the migration of neutrophils isolated from the BM of three different genetically engineered models (GEMs) of cancer in mice: RET melanoma ('RET mice') 24 , KPC pancreatic cancer ('KPC mice') 25 and TRAMP prostate cancer ('TRAMP mice') 26 . These mice were backcrossed for more than ten generations to the C57BL/6 N background. Neutrophils were phenotypically characterized as CD11b + Ly6C lo Ly6G + and were isolated on the basis of their expression of the marker Ly6G. The migration and chemotaxis of neutrophils were assessed by a standard Transwell membrane assay. In all three models, we observed substantially more migration of neutrophils from TB mice in response to the chemokine CXCL1 or the chemoattractant fMLP than that of neutrophils from their tumor-free littermates (control mice) ( Fig. 1a ). However, when we evaluated the ability of these stimuli to induce cell migration (the ratio of stimulated cells to unstimulated cells), we observed no difference between TB mice and tumor-free mice (Fig. 1a) . Instead, we observed much more spontaneous migration of neutrophils in TB mice than in tumor-free mice (Fig. 1b ). No or very small differences between those mice were evident in their expression of the CXCL1 receptors CXCR1 and CXCR2 ( Fig. 1c) , consistent with the results for neutrophil chemotaxis. Although the total number of neutrophils was significantly higher in the BM of KPC mice than in that of control mice, the total number of neutrophils from RET mice and TRAMP mice was similar to that of control mice ( Supplementary Fig. 1a ), which suggested that the changes in motility were not associated with the population expansion of neutrophils in BM.
To confirm that the differences in migration were not limited to the BM, we isolated neutrophils from the peripheral blood of RET mice and their control counterparts. Neutrophils from TB mice demonstrated greater spontaneous and CXLC1-induced migration than that of neutrophils from control mice ( Fig. 2a ). When we evaluated the migratory activity of BM neutrophils in models of mice given subcutaneous transplantation of tumors (EL4 lymphoma ('EL4 mice'), LLC lung carcinoma ('LLC mice') or CT26 colon carcinoma ('CT26 mice')), we observed no difference between control mice and TB mice in the migration of these cells (Fig. 2b) . The number of BM neutrophils was markedly higher in TB EL4 mice than in control mice ( Supplementary Fig. 1b ). We analyzed by time-lapse microscopy the movement of cells on fibronectin-coated surfaces. BM neutrophils from RET mice, but not those from EL4 mice, demonstrated a greater capacity to spontaneously migrate than that of BM neutrophils from control mice ( Fig. 2c and Supplementary Video 1), and this was characterized by markedly greater meansquared displacement over time (Fig. 2d ), speed ( Fig. 2e) , persistence time ( Fig. 2f ) and random motility coefficient (Fig. 2g ).
To confirm our hypothesis that how a tumor is established in mice has a critical effect on neutrophil motility, we investigated the migratory activity of BM neutrophils from a transplantable tumor model established by subcutaneous injection of 4662 cells, a subline of tumor cells derived from KPC mice 27 . In contrast to neutrophils from KPC mice, neutrophils from mice given subcutaneous injection of 4662 cells did not display greater spontaneous or chemokine-induced migration than that of mice not given injection of cells (Fig. 3a) .
We hypothesized that inflammation caused by the injection of a large number of tumor cells at the ectopic site could explain the lack of enhanced spontaneous migration of neutrophils in subcutaneous transplantable models. To test our hypothesis, we used an orthotopic model of lung cancer by intravenously injecting a small number of luciferase-expressing LL2 (Lewis lung carcinoma) tumor cells (1 × 10 5 ); this resulted in the formation of tumor lesions in the lungs within 1 week of injection ('1-week mice') and large lesions 3 weeks after injection ('3-week mice') ( Supplementary Fig. 1c ). The total number of BM neutrophils was substantially increased at 3 weeks after injection but not 1 week after injection ( Supplementary Fig. 1d ). BM neutrophils from 1-week mice had much greater spontaneous and CXCL1-induced migration than that of BM neutrophils from control mice (Fig. 3b,c) . However, when cells were isolated 3 weeks after injection, no such differences were observed (Fig. 3b,c) . To verify those observations in vivo, we isolated BM neutrophils from congenic LL2 TB (CD45.1 + ) mice and tumor-free (CD45.2 + ) mice (control mice), mixed them at a ratio of 1:1 and injected them intravenously into CD45.1 + CD45.2 + tumor-free recipient mice. The ratio of CD45.1 + neutrophils to CD45.2 + neutrophils was evaluated in spleens and lungs of the host mice at 1 h after injection. In both tissues, neutrophils from 1-week mice were more prevalent than control neutrophils (Fig. 3d) , indicative of increased migratory ability. In contrast, the ratio of neutrophils from 3-week mice to neutrophils from control mice was lower than 1 (Fig. 3e ), indicative of lower migratory ability of neutrophils from 3-week mice than that of neutrophils from control mice, in the spleen and lungs.
We sought to determine whether an association between the stage of tumor development and neutrophil activity would be observed in mice of each GEM. The KPC model could be used to address this question. By 8-10 weeks of age, KPC mice develop pancreatic intraepithelial neoplasia (PanIN). They also develop spontaneous pancreatic ductal adenocarcinoma (PDA) with 100% penetrance 25 , and by 16 weeks of age, most have developed locally invasive PDA. Therefore, we were able to separately evaluate mice at the relatively early (PanIN) stage of pancreatic-cancer development and those at the relatively late stage (invasive PDA). We found that only mice with PanIN, not those with invasive PDA, had greater spontaneous migration of neutrophils than that of control mice, as assessed by Transwell assay (Fig. 3f ) and the mean squared displacement assay ( Fig. 3g ).
Thus, in GEMs of melanoma and pancreatic and prostate cancer and at early stages of orthotopic lung cancer, BM neutrophils demonstrated a substantial capacity to spontaneously migrate. In contrast, BM neutrophils from the subcutaneous transplantable tumor models and the 3-week orthotopic lung-cancer model (with substantial tumor burden) exhibited migratory activity similar to that of neutrophils from tumor-free (control) mice.
BM neutrophils in the early stages of lung cancer are functionally different from those in the late stages. To investigate the differences between mouse BM neutrophils in early stages of orthotopic lung cancer and those in advanced stages, we performed gene expression profiling by RNA sequencing (RNA-seq). In a comparison of gene expression in neutrophils from 1-week or 3-week TB mice versus that in neutrophils from control mice, neutrophils from 3-week TB mice had more genes with significantly different expression than did neutrophils from 1-week TB mice ( Fig. 4a ). Ingenuity pathway analysis revealed that the network most enriched in BM neutrophils from 1-week LL2 TB mice, but not in those from 3-week LL2 TB mice, was 'energy production, nucleic-acid metabolism and smallmolecule biochemistry' ( Supplementary Fig. 2 ). The expression of genes in the EIF2 signaling pathway associated with endoplasmic reticulum (ER) stress was significantly upregulated in neutrophils from 1-week and 3-week LL2 mice relative to their expression in neutrophils from tumor-free (control) mice ( Supplementary Fig. 3 ). Neutrophils from 3-week LL2 mice had substantial upregulation of genes encoding molecules in multiple pathways associated with inflammatory responses, reactive oxygen species (ROS) and oxidative stress response, signaling via inducible nitric oxide synthase and ER stress, relative to their expression neutrophils from 1-week LL2 mice ( Fig. 4b ). Most of these pathways have been previously linked to PMN-MDSC function 28 . Consistent with those results, the expression of genes regulated by the transcription factor XBP1, lipopolysaccharide, the cytokine IL-1, the transcription factor HIF1A, the cytokine TNF and the transcription factor ATF4 was higher in 3-week LL2 mice than in 1-week LL2 mice ( Fig. 4c ). These results suggested that the BM neutrophils in 3-week mice, but not those in 1-week LL2 mice, could have been genuine PMN-MDSCs.
To functionally verify those observations, we evaluated the ability of BM neutrophils to suppress antigen-specific T cell responses. The neutrophils from 1-week TB mice showed minimal suppressive activity, whereas neutrophils from 3-week TB mice exhibited potent suppressive activity ( Fig. 5a ). BM neutrophils from tumorfree (control) mice were not suppressive. Similar to their counterparts from 1-week LL2 mice, BM neutrophils from RET mice ( Fig. 5b ) and KPC or TRAMP mice ( Fig. 5c ) did not suppress T cell responses. In contrast, BM neutrophils from LLC mice or EL4 mice suppressed T cell proliferation ( Fig. 5b) . In a separate set of experiments, we compared suppression by BM neutrophils isolated from KPC mice with PanIN and that by BM neutrophils from their counterparts with PDA. Neutrophils from mice with PanIN had no suppressive activity, whereas neutrophils from mice with PDA had substantial suppressive activity ( Fig. 5d ).
Since ROS production and the oxidized stress response were among the main pathways upregulated in neutrophils from 3-week LL2 TB mice, we evaluated the level of cytoplasmic ROS produced by neutrophils. BM neutrophils from 3-week LL2 mice had markedly greater cytoplasmic ROS than that of neutrophils from tumor-free (control) mice, but those from 1-week LL2 mice did not ( Supplementary Fig. 4a ). Neutrophils from RET mice had ROS production similar to that of tumor-free (control) mice ( Supplementary Fig. 4b ), whereas BM neutrophils from LLC mice or EL4 mice had a slightly elevated ROS level relative to that of neutrophils from control mice ( Supplementary Fig. 4c ). To better understand the mechanism that regulated the functional differences between PMNs at early stages of cancer and those at late stages, we assessed the cytokine profile of serum from 1-week and 3-week LL2 mice. We observed upregulation (more than 2 s.d.) of the expression of many pro-inflammatory cytokines (G-CSF, GM-CSF, IFN-γ , IL-1β , IL-17, TREM-1 and TNF) in mice with 3-week mice relative to their expression in 1-week mice ( Fig. 5e ).
Thus, we concluded, on the basis of their functional characteristics, that BM neutrophils from 3-week LL2 orthotopic mice and LLC or EL4 mice and, to some extent, KPC mice with invasive PDA, were typical PMN-MDSCs. BM neutrophils from 1-week LL2 mice and from mice of GEMs of cancer were not PMN-MDSCs. However, they had elevated levels of genes encoding components of the ER stress response. We provisionally called these 'PMN-MDSClike cells' (PM-LCs). This term was coined previously to describe a population of activated neutrophils in cancer that did not acquire the full capacity to suppress immune responses 8 .
PM-LCs and PMN-MDSCs are metabolically distinct.
Next we evaluated oxidative phosphorylation and glycolysis in BM neutrophils. We observed that BM PM-LCs from 1-week LL2 mice had a markedly higher oxygen-consumption rate (OCR) than that of control neutrophils, indicative of increased oxidative phosphorylation in the former cells. In contrast, PMN-MDSCs from 3-week LL2 mice had an OCR similar to that of control neutrophils (Fig. 6a ). BM PM-LCs isolated from RET mice also demonstrated a significantly higher OCR than that of control neutrophils (Fig. 6b ). In contrast, BM PMN-MDSCs from EL4 mice had an OCR similar to that of control cells ( Fig. 6c ). PM-LCs from 1-week LL2 mice also had a markedly higher extracellular acidification rate (ECAR) than that of control cells ( Fig. 6d ), indicative of increased glycolysis. BM PMN-MDSCs from 3-week LL2 mice had an ECAR similar to that of control cells. PM-LCs from RET mice also had a higher ECAR than that of control neutrophils (Fig. 6e ). No differences were observed between BM PMN-MDSCs from EL4 mice and control cells ( Fig. 6f ). Thus, BM PM-LCs from the early stages of orthotopic lung cancer and from RET mice demonstrated greater oxidative phosphorylation and glycolysis than that of control neutrophils or PMN-MDSCs. We then performed metabolomics analysis of 13 C 6 -glucose through glycolysis ( Supplementary Fig. 5 ) in neutrophils from tumor-free (control) mice and PM-LCs from 1-week TB mice. BM PM-LCs had more uptake of glucose, along with higher intracellular levels of pyruvate, citrate and lactate, than that of control neutrophils. They also secreted markedly more lactate (Fig. 6g ). In addition, PM-LCs had much higher rates of incorporation of the 13 13 C atoms in each metabolite) ( Fig. 6g) . The 13 C-labeling patterns we observed for PM-LCs strongly indicated that there was greater flux of glucose carbon through glycolysis and into the tricarboxylic acid (TCA) cycle in the PM-LCs. As a consequence of that accelerated glycolysis and flux through the TCA cycle, PM-LCs had significantly larger amounts of ATP ( Fig. 6h ). In contrast to results obtained for PM-LCs, metabolomics analysis of BM PMN-MDSCs Fig. 3 | Neutrophils from the early stages of an orthotopic lung cancer model exhibit increased spontaneous migration, but those from late stages do not. a, Transwell assay of BM neutrophils from control mice and TB mice given subcutaneous injection of 4662 cells (n = 4 mice per group), assessing the ability of neutrophils to spontaneously migrate (left) and to move by chemotaxis in response to various concentrations (horizontal axis) of CXCL1 (middle) or fMPL (right). P values (not shown), not significant (two-sided Student's t-test). b,c, Transwell assay of neutrophils from control and 1-week or 3-week LL2 mice (above plots; 1-week, n = 5 (control) or n = 6 (LL2); 3-week, n = 3 (control) or n = 4 (LL2)), assessing the ability of neutrophils to spontaneously migrate (b) and to move by chemotaxis in response to various concentrations (horizontal axis) of CXCL1 (c from 3-week LL2 mice showed that PMN-MDSCs did not have greater 13 C-labeling of pyruvate and lactate than that of neutrophils from control mice, nor were there any differences in the efflux of lactate into the medium ( Supplementary Fig. 6a ). There were also no differences observed in the level of ATP in neutrophils and that in PMN-MDSCs ( Supplementary Fig. 6b ). These results were in agreement with the OCR and ECAR analyses, for which there were no differences in oxidative phosphorylation or glycolysis in PMN-MDSCs relative to that of control neutrophils. The increased metabolism of BM PM-LCs was not associated with increased mitochondrial mass ( Supplementary Fig. 4d ).
Because neutrophils have few mitochondria and use chiefly glycolysis to generate ATP 29 , we hypothesized that two main mechanisms could account for the increased glucose metabolic rate in PM-LCs: (1) an increase in the expression of glycolytic enzymes and (2) an increase in glucose uptake. PM-LCs had higher expression of the glucose transporter Glut1 than that of neutrophils from tumorfree mice (control cells), but PMN-MDSCs did not ( Supplementary  Fig. 6c,d) , which might explain the increased glucose uptake by PM-LCs. We did not observe differences between control neutrophils and PM-LCs from RET mice in their expression of major glycolytic enzymes ( Supplementary Fig. 7a ), consistent with the results obtained by RNA-seq. Thus, PM-LCs had high glucose uptake, increased oxidative phosphorylation, increased TCA-cycle flux and increased glycolysis, which resulted in substantially greater production of ATP than that of neutrophils from control mice; this might have accounted for their increased migratory ability. This effect was absent from PMN-MDSCs. RNA-seq analysis of the gene-expression profiles of BM neutrophils (three samples per group) isolated from naive mice (control), 1-week LL2 TB mice (w1) or 3-week LL2 TB mice (w3), presented as the total genes with altered expression in various comparisons (above plots) and the overlap of those groups (middle of each plot) (a) and the expression of genes with a significant change in expression (false-discovery rate < 5%) in 3-week LL2 TB mice relative to that in 1-week LL2 TB mice, for genes encoding components of various pathways (horizontal axis) (b) or genes encoding various regulators (horizontal axis) (c).
Increased spontaneous migration of PM-LCs in cancer is regulated by ATP.
ATP-mediated autocrine signaling can enhance gradient sensing and chemotaxis of neutrophils 30 . We hypothesized that BM PM-LCs might use ATP-mediated autocrine signaling as a mechanism to support their enhanced spontaneous migration. ATP can be released from cells through mechanosensitive channels, such as pannexin-1 and connexin hemichannels 31, 32 . We assessed the effect of disrupting the release of ATP from the cell on the ability of PM-LCs to spontaneously migrate. We inhibited pannexin-1 hemichannels through the use of 10 Panx, a pannexin-1 mimetic inhibitory small peptide. This resulted in the abolition of the increased spontaneous migration exhibited by PM-LCs from RET mice and 1-week LL2 TB mice (Fig. 7a) . We confirmed the specificity of the effect with a scrambled version of 10 Panx, which had no effect on the spontaneous migration of PM-LCs (Fig. 7a ). To verify that the spon-taneous migration was truly dependent upon ATP, we treated cells with apyrase, an enzyme that catalyzes the hydrolysis of ATP. After treatment with apyrase, the spontaneous migration of both control neutrophils and PM-LCs was completely abolished (Fig. 7b ).
There are several families of ectonucleotidases expressed on the surface of mammalian cells that can hydrolyze ATP to ADP, AMP and adenosine, and each of these metabolites can signal through a distinct set of purinergic receptors 33 . Neutrophils have been reported to use the purinergic receptors P2X 1 , P2Y 1 and P2Y 2 , which bind ATP, and A3, which binds adenosine, to amplify chemotactic signals 30, 34 . To determine if these receptors were involved in the spontaneous migration of PM-LCs, we treated cells with suramin, a pan-P2 receptor inhibitor and observed that the spontaneous migration of PM-LCs was completely abolished (Fig. 7c) . To clarify the role of individual purinergic receptors, we treated cells with NF449, a P2X 1 -specific inhibitor. The ability of PM-LCs to spontaneously migrate was inhibited only partially (50%) by this ( Fig. 7d ). However, blocking P2Y 1 or P2Y 2 through the use of the selective inhibitors MRS 2179 or AR-C118925XX, respectively, completely abolished the increased spontaneous migration (Fig. 7e ). In contrast, blocking the A3 receptor with the inhibitor MRS 1191 did not affect the migration of PM-LCs (Fig. 7f) . These data indicated that increased production of ATP by PM-LCs in TB mice was directly involved in the increased spontaneous migration of these cells, in a paracrine fashion. If increased production of ATP and paracrine signaling were a major mechanism of the increased spontaneous migration of PM-LCs, then activating the purinergic receptors would increase the spontaneous migration of control neutrophils and PMN-MDSCs. To test that hypothesis, we treated these cells with ADP and observed significantly increased migration (Fig. 7g ).
Next we investigated the signaling pathways by which ATP could affect spontaneous neutrophil migration. Neutrophil migration requires polarization of the front and rear of the cell, processes that are coordinated by the Rho guanosine triphosphatases (GTPases) Rac, Cdc42 and RhoA 35 . Activation of Rac at the leading edge of the cell induces actin polymerization, and signaling via Cdc42 can steer the direction of migration 36 . We evaluated actin polarization (F-actin) in neutrophils. Stimulation with either CXCL1 or fMLP resulted in substantial increase in F-actin. However, we found no difference between unstimulated BM neutrophils from control mice or PM-LCs from TB mice of the RET, KPC or TRAMP models versus their stimulated counterparts ( Supplementary Fig. 7b,c) . The rear of the cell generates the contractile force that is needed to overcome any cell adhesions and move the cell body forward. This process is regulated by activation of the kinase ROCK, which phosphorylates Ser19 on the regulatory myosin light chain MLC2 21 . We evaluated the target of ROCK activity (phosphorylated MLC2) and found that PM-LCs from 1-week LL2 TB mice had substantial upregulation of phosphorylated MLC2 relative to that in control neutrophils (Fig. 7h ). The selective P2Y 2 inhibitor AR-C118925XX abolished the upregulation of phosphorylated MLC2 in PM-LCs ( Supplementary Fig. 7e ).
Increased neutrophil migration is associated with increased tumor spread. Next we evaluated the migratory activity of neutrophils from patients with cancer. Neutrophils were isolated from peripheral blood by negative selection, and their response to stimulation with the chemokine CXCL8 (IL-8) or fMLP was assessed. Neutrophils from patients with cancer demonstrated much greater spontaneous migration than that of neutrophils obtained from healthy donors (Fig. 8a) . This was associated with more potent response to both CXCL8 and fMLP (Fig. 8b) . Neutrophils from healthy donors and patients with cancer had similar expression of the chemokine receptors CXCR1 and CXCR2 (Fig. 8c) . We compared the motility of neutrophils and PMN-MDSCs obtained from the same patient. CD15 + PMN-MDSCs were isolated from the low-density peripheral blood mononuclear cells through the use of magnetic beads 8 . CD15 + neutrophils were also isolated from the high-density fraction through the use of magnetic beads 37 . Neutrophils exhibited substantially greater spontaneous CXCL8-stimulated migration than that of PMN-MDSCs from the same patient (Fig. 8d,e ). PMN-MDSCs were found to have lower expression of CXCR1 and CXCR2 than that of neutrophils from the same patient (Fig. 8f ), which might have accounted for their diminished response to CXCL8. Despite the marked difference in migration, neutrophils and PMN-MDSCs had similar level of actin poly merization ( Supplementary Fig. 7d ), a finding consistent with the results obtained with TB mice. These data suggested that neutrophils from patients with cancer had greater spontaneous and chemokine-induced migration than neutrophils from healthy donors, but PMN-MDSCs did not. We sought to determine whether the increased spontaneous motility of PM-LCs could facilitate tumor-cell seeding. To test this hypothesis, we performed two types of experiments in which we assessed the role of neutrophils in promoting tumor-cell seeding of the lungs after intravenous injection. In the first group of experiments, BM neutrophils from control mice, PM-LCs from 1-week LL2 mice and PMN-MDSCs from 3-week LL2 mice were injected intravenously into tumor-free recipients 5 h before the injection of LL2 tumor cells labeled with the division-tracking dye CFSE. The presence of tumor cells in lungs was evaluated 12 h later. The administration of PM-LCs caused significantly more seeding of tumor cells than did the administration of control neutrophils, but the administration of PMN-MDSCs did not (Fig. 8g ). In the second group of experiments, control neutrophils, PM-LCs and PMN-MDSCs were injected intravenously 5 h before the administration of luciferase-expressing LL2 tumor cells, and tumor growth was assessed 14 d later by measurement of luciferase luminescence. All mice developed tumors. The administration of PMN-MDSCs slightly increased the tumor burden; however, it was significantly larger after the administration of PM-LCs (Fig. 8h) . Thus, PM-LCs 'preferentially' facilitated tumor-cell seeding, and it is possible that once PM-LCs are in the tissue, these cells could facilitate tumor-cell metastasis ( Supplementary Fig. 8 ).
Discussion
Our study has described the association of the functional state of neutrophil activation in cancer with the ability of these cells to spontaneously migrate. It is likely that the population of neutrophils in TB mice or patients with cancer consists of classic neutrophils and a smaller population of pathologically activated, immunosuppressive PMN-MDSCs. The abundance of PMN-MDSCs depends on the stage and type of cancer 5 . PMN-MDSCs usually accumulate in advanced-stage cancer and are often barely detectable in the early and patients with cancer (below plot; n = 24 per group). b, Migration of neutrophils from healthy donors and patients with cancer (below plot) in response to medium alone (Med) (n = 24 (HD) or n = 14 (patients)) or stimulation with CXCL8 (n = 10 (HD) or n = 3 (patients)) or fMLP (n = 6 (HD) or n = 3 (patients)). c, Expression of CXCR1 (left) and CXCR2 (right) (each tagged with phycoerythrin (PE)) in neutrophils from healthy donors (n = 7 per group) and patients with cancer (n = 4 (CXCR1) or n = 6 (CXCR2)) (horizontal axis), assessed by flow cytometry and presented as geometric mean fluorescence intensity (gMFI). d,e, Spontaneous migration of PMNs and PMN-MDSCs (horizontal axis) from patients with cancer (n = 12) (d) and of PMNs and PMN-MDSCs from those same patients after stimulation with CXCL1 (n = 11 (PMN) or n = 13 (PMN-MDSC)) (e). f, Expression of CXCR1 (left) and CXCR2 (right) (tagged as in c) on PMN-MDSCs and PMNs from patients with cancer (n = 4 (CXCR1) or n = 6 (CXCR2)), assessed and presented as in c. g, Frequency of CD45 -CFSE + (live) LLC cells in the lungs of naive host mice given injection of Ly6G + PMNs from the BM of naive mice (n = 7), PM-LCs from 1-week LL2 mice (n = 5), or PMN-MDSCs from 3-week LL2 mice (n = 5) (horizontal axis) 5 h before intravenous injection of CFSE-labeled LL2 tumor cells, followed by analysis 12 h later. h, In vitro imaging system-based analysis of ex vivo luciferase activity in lungs excised from naive host mice (n = 3) given intravenous injection of BM Ly6G + cells 5 h before intravenous injection of luciferase-expressing LL2 tumor cells, followed by analysis of luciferase activity 2 weeks after the final injection. Each symbol represents an individual donor or patient (a-f) or mouse (g,h); small horizontal lines indicate the mean ( ± s.d.). *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (two-sided Student's t-test).
stages. Although PMN-MDSCs can be detected in BM, their suppressive activity in BM is much lower than that of cells in the spleen and tumor site 3 . Our data confirmed the presence of PMN-MDSCs in the BM of mice with various subcutaneous (ectopic) tumors and in mice with advanced orthotopic lung cancer. However, immunosuppressive BM PMN-MDSCs were not found in mice of GEMs of cancer or in early-stage orthotopic lung cancer. It is possible that the degree of the inflammation associated with the different tumor models has a role in this. Ectopic tumors that require the subcutaneous injection of a relatively large number of tumor cells are associated with local inflammation that might facilitate the rapid development of PMN-MDSCs. The same phenomenon is associated with late-stage orthotopic or spontaneous cancers in which the mice have a large tumor burden. BM neutrophils from mice with early-stage orthotopic lung cancer and GEMs of cancer did not have immunosuppressive activity. However, BM neutrophils in these models had elevated expression of genes encoding components of the ER stress pathway, one of the characteristics of pathological activation of these cells in cancer 38 . We found that these cells were markedly different from BM neutrophils from tumor-free (control) mice in their ability to spontaneously migrate. They also had increased expression of genes encoding molecules associated with energy production, nucleic acid metabolism, increased oxidative phosphorylation and glycolytic rates, and they had considerably more ATP that of control neutrophils. The term 'MDSC-like cells' was introduced to characterize pathologically activated myeloid cells that had not yet acquired potent suppressive activity 8 . We have used the term 'PMN-MDSC-like cells' (PM-LCs) to define the functional state of BM neutrophils from mice with early-stage orthotopic lung cancer and GEMs of cancer that did not have immunosuppressive activity.
Why did the PM-LCs have a potent ability to spontaneously migrate? In order to move, neutrophils must acquire spatial asymmetry. The crosstalk between the front of the cell and the rear of the cell that maintains this polarization is poorly understood but is believed to be maintained by coordinated GTPase signaling among Rac, Cdc42 and RhoA 35 . In migrating neutrophils, the formation of leading-edge protrusions (lamellipods) is caused by the polymerization of monomeric globular actin (G-actin) into filamentous actin (F-actin). The rear of the cell (the uropod) generates the contractile force that is needed to overcome any cell adhesions and move the cell body forward. Activation of RhoA leads to the activation of ROCK, which directly phosphorylates Ser19 on MLC2 39 . We were focused on the two endpoints of the signaling cascades that result in neutrophil migration: F-actin polymerization and phosphorylation of MLC2. Although, as expected, the abundance of F-actin was substantially increased in neutrophils in response to stimuli, we observed no difference between control neutrophils and PM-LCs. In contrast, PM-LCs had substantially more phosphorylated MLC2, which indicated the involvement of contractile forces in the rear of the cells as the driving force supporting the increased spontaneous migration of PM-LCs.
What drove the increased migration of PM-LCs? Our study has demonstrated that BM PM-LCs had increased ATP, whereas BM PMN-MDSCs had ATP levels similar to those of control neutrophils. This paralleled the changes in migratory capacity. The metabolism of MDSCs in cancer is not well understood. In MDSCs generated in vitro, glycolysis increased concurrently with increased arginase I activity and activation of AMP-activated protein kinase, which can drive metabolism toward fatty-acid oxidation (FAO) 40 . Tumorinfiltrating MDSCs used mainly FAO and oxidative phosphorylation as their chief metabolic pathway. In support of that finding, tumor-infiltrating MDSCs have increased fatty-acid uptake and upregulate key FAO enzymes 41 . Our data have demonstrated that the increased metabolism and ATP in BM PM-LCs preceded their acquisition of the functional immunosuppressive characteristics of PMN-MDSCs. Since BM PM-LCs are the cells that 'preferentially' migrate into tissues, our data are consistent with the observations of the metabolism of PMN-MDSCs in tumors.
Published studies have shown that neutrophils release ATP in response to chemokines and that autocrine signaling serves to amplify the chemotactic signal 30 . ATP is released through connexin and pannexin-1 hemichannels 31 and binds to three main families of purinergic receptors: P1, P2X and P2Y 33 . P2Y 2 and A3 are important mediators of extracellular ATP and, with the ATP ectonucleotidase CD39, aid in the polarization of neutrophils by translocating to the leading edge of the cell 30, 31 . P2X1 has been linked to the activation of RhoA and the phosphorylation of MLC2 in human and mouse neutrophils 34 . By blocking purinergic receptors and ATP hydrolysis in this study, we demonstrated a direct role for ATP in supporting the greater spontaneous migration of PM-LCs than that of neutrophils from tumor-free (control) mice. At the same time, ADP, a ligand of purinergic receptors, substantially increased the spontaneous migration of control neutrophils and PMN-MDSCs, in support of the notion that the release of ATP might be sufficient to drive high PM-LC motility.
In line with our studies of mice, peripheral blood neutrophils from patients with cancer exhibited much greater spontaneous migration than that of neutrophils from healthy donors. PMN-MDSCs had substantially reduced migration, consistent with a published report of a population of human PMN-MDSCs with low migratory activity 23 . Genuine PMN-MDSCs are capable of migrating toward a chemokine gradient, such as one leading to the tumor site, but have very poor ability to migrate to uninvolved tissues. There is now ample evidence that neutrophils can acquire features of PMN-MDSCs in the tissues of TB hosts 5 . PM-LCs might represent the first step of the pathological activation of neutrophils in cancer. These cells have a more-potent ability to migrate to distant sites in the absence of inflammation or tumor cells than that of control neutrophils or PMN-MDSCs.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41590-018-0229-5.
threshold of a change in expression of over fivefold taken to generate the final gene set. Gene set enrichment analysis was done using QIAGEN's Ingenuity Pathway Analysis software (https://www.qiagen.com/ingenuity) based on the 'Functions' , 'Canonical Pathways' , 'Upstream Regulators' and 'Networks' options.
Suppression assays. After isolation of BM Ly6G + cells as described above, cells were plated in U-bottomed 96-well plates in triplicates in complete RMPI without extra cytokines. They were co-cultured at various ratios with total splenocytes from Pmel or OT-I mice in the presence of cognate peptides (OT-I, SIINFEKL; Pmel, EGSRNQDWL). Cells were incubated for 48 h, and then 3 H thymidine (PerkinElmer) was added (1 μ l/well), followed by incubation overnight. The radioactivity of samples was counted with a TopCount NXT instrument (PerkinElmer).
In vivo tumor experiments. In the short-term lung metastasis model, LLC cells were labeled with CFSE (BioLegend). 1 × 10 6 CFSE-labeled LLC cells were intravenously injected 5 h after intravenous injection of 1 × 10 6 BM Ly6G + cells isolated from naive mice or 1-week or 3-week LL2 TB mice. At the appropriate time, mice were killed and their lungs were collected after perfusion with PBS to eliminate circulating tumor cells. Lungs were cut into small pieces and digested with a Lung Dissociation Kit according to the manufacture's protocol (Miltenyi Biotec). Subsequently, the lungs were passed through a 70-μ m cell strainer and were subjected to red-bloodcell lysis using ammonium-chloride-potassium (ACK) buffer. Lung single-cell suspensions were stained with anti-CD45-APC-Cy7 (BD Biosciences).
For long-term lung metastasis model, 5 × 10 4 LL2 cells were intravenously injected 5 h after intravenous injection of 2 × 10 6 BM Ly6G + cells isolated from naive mice or 1-week or 3-week LL2 TB mice. Mice were killed 14 d after injection and the tumor burden was analyzed. The luciferase signal was measured in excised lungs with an IVIS Spectrum imaging system (Caliper).
Time-lapse migration assay.
The wells of a 12-well plate were coated with 50 μ g/ml fibronectin (Sigma-Aldrich) and were washed with PBS. Cells were plated (0.5 × 10 6 cells per well) in Advanced RPMI (Thermo Fisher, cat. no.: 12633-012) without FBS and were placed in a 37 °C and 5% CO 2 incubator for 10-15 min to allow cell attachment. The wells were gently washed with 2 × PBS to remove non-adherent cells, and Advanced RPMI was added to the wells. Cells were placed onto a motorized stage and were observed wth a Nikon Eclipse TE 300 fluorescence microscope maintained in an environment of 37 °C and 5% CO 2 . A 10 × or 20 × objective was used to capture images during the course of the time lapse. Images were captured every 30 s over the course of 15 min from at least four different fields of view.
Measurement of cell trajectories and mean-squared displacements.
Cell movement was tracked using the ImageJ plugin Manual Tracking. ImageJ and the plugin are both freely available through the NIH website (http://rsbweb.nih.gov/ij/). The centroid of the cell was considered to represent the cell position. Time-lapse microscopy was used, and images were taken every 1.5 min. The result was a series of (x,y) positions with time for each cell. The net displacement during the ith 1.5min increment, D i , was calculated by the difference of the position at the beginning and end of that time step. The mean-squared displacement, ⟨ ⟩ D t ( ) 2 , over time was calculated bt the method of non-overlapping intervals. Speed, S, can be considered as the total path length over time and persistence time, P, is the time a cell remains moving without changing direction. S and P were obtained by fitting these to the persistent random walk equation
, where t is the time interval, using a nonlinear least-squares regression analysis 45, 46 . The random motility coefficient (μ ) was then calculated as μ = S P 1 2 2 47 .
Cytokine protein array. Expression of cytokines in mouse sera was evaluated using mouse cytokine antibody array Panel A (ARY006, R&D Systems). Serum from 1-week and 3-week LL2 TB mice was mixed with a 'cocktail' of biotinylated detection antibodies, followed by streptavidin-labeled horseradish peroxidase and then visualization by chemiluminescence-based detection. Densities of the spots were quantified with Image J. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Flow cytometry data was collected using BD FACSDiva software. Seahorse assay data was collected using Wave v2.4.
Data analysis
Metabolite identification and quantitation was performed with TraceFinder 3.1 (Thermo Fisher Scientific). Flow cytometry data was analyzed using FlowJo v9.6.2 (Tree Star, Inc.). Seahorse assay data was analyzed using Wave v2.4. Data analysis was also conducted using Prism v 7.0 (GraphPad Software).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. Animals and other organisms Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals
Female and male C57BL/6 CD45.1+ and female C57BL/6 CD45.2+ mice (aged 6-8 weeks) were purchased from Charles River Laboratories. Female C57Bl/6 CD45.1+/2+ were generated by crossing a male CD45.1+ with a female CD45.2+. Female OT-I TCRtransgenic mice (C57Bl/6-Tg(TCRaTCRb)1100mjb) (4-6 week old) and female Pmel TCR-transgenic mice (B6.Cg-Thy1a/Cy Tg(TcraTcrb)8Rest) (4-6 week old) were purchased from Jackson Laboratories.
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
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The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation
